1. WHO. Global Vaccine Safety. Adverse events following immunization (AEFI). Accessed 16 May 2018.

  2. Zvanaka S, Tsitsi J, Chonzi P, Shambira G, Gombe NT, Tshimanga M. Evaluation of the adverse events following immunizations surveillance system in Harare City, Zimbabwe, 2016: a descriptive cross sectional study. Pan African Medical Journal. 2017 Dec 13; 28: 308. PubMed | Google Scholar

  3. General Practice Notebook. Adverse events following immunisation (AEFIs). Accessed 16 May 2018.

  4. Edwards KM, Meade BD, Decker MD, Reed GF, Rennels MB, Steinhoff MC et al. Comparison of 13 Acellular Pertussis Vaccines: overview and serologic response. Pediatrics. 1995; 96(3 Pt 2): 548-557. PubMed | Google Scholar

  5. WHO. Immunization, Vaccines and Biologicals. SAGE issues its 2018 assessment report of the Global Vaccine Action Plan. Global Vaccine Action Plan. Accessed 16 May 2018.

  6. Lei J, Balakrishnan MR, Gidudu JF, Zuber PLF. Use of a new global indicator for vaccine safety surveillance and trends in adverse events following immunization reporting 2000-2015. Vaccine. 2018; 36(12): 1577-1582. PubMed | Google Scholar

  7. Sow SO, Okoko BJ, Diallo A, Viviani S, Borrow R, Carlone G et al. Immunogenicity and Safety of a Meningococcal A Conjugate Vaccine in Africans. New England Journal of Medicine. 2011; 364(24): 2293-2304. PubMed | Google Scholar

  8. London School of Hygiene and Tropical Medicine. The use of epidemiological tools in conflict-affected populations: open-access educational resources for policy-makers. Types of surveillance. 2009. Accessed 16 May 2018.

  9. Ministry of Health and Child Care. Adverse Events Following Immunization Surveillance Guidelines. 3rd Edition Jan 2017. Accessed 16 May 2018.

  10. Kibombo R, Asiimwe D, Matsiko J. Vaccine safety perceptions among parents in developing countries and influence of adverse events following immunization (AEFI) on their decisions to vaccinate children. 2006. Accessed 17 May 2018.

  11. Mehta U, Milstien JB, Duclos P, Folb PI. Developing a national system for dealing with adverse events following immunization. Bull World Health Organ, Bull World Health Organ. 2000; 78(2): 170-177. PubMed | Google Scholar

  12. Graham JE, Borda-Rodriguez A, Huzair F, Zinck E. Capacity for a global vaccine safety system: the perspective of national regulatory authorities. Vaccine. 2012; 30(33): 4953-4959. PubMed | Google Scholar

  13. Masika CW, Atieli H, Were T. Knowledge, perceptions and practice of nurses on surveillance of adverse events following childhood immunization in Nairobi, Kenya. Biomed Res Int. 2016; 2016: 3745298. PubMed | Google Scholar

  14. Samsiah A, Othman N, Jamshed S, Hassali MA. Perceptions and attitudes towards medication error reporting in primary care clinics: a qualitative study in Malaysia. PLoS One. 2016; 11(12): e0166114. PubMed | Google Scholar

  15. Muchekeza M, Chimusoro A, Ncube N, Pomerai KW. Adverse events following immunisation (AEFI) surveillance in Kwekwe District, Midlands Province, Zimbabwe, 2009-2010. Journal of Vaccines and Vaccination. 2014; 5(3): 232.

  16. Cashman P, Macartney K, Khandaker G, King C, Gold M, Durrheim DN. Participant-centred active surveillance of adverse events following immunisation: a narrative review. Int Health. 2017; 9(3): 164-176. PubMed | Google Scholar

  17. Tsafack M, Ateudjieu J. Improving community based AEFI (Adverse Events Following Immunization) reporting rate through telephone "beep" in a Cameroon health district: a randomized field trial. Pan Afr Med J. 2015 Dec 11; 22: 351. PubMed | Google Scholar

  18. Ndwiga C, Abuya T, Mutemwa R, Kimani JK, Colombini M, Mayhew S et al. Exploring experiences in peer mentoring as a strategy for capacity building in sexual reproductive health and HIV service integration in Kenya. BMC Health Serv Res. 2014; 14: 98. PubMed | Google Scholar